Journal
NANOMEDICINE
Volume 14, Issue 11, Pages 1367-1370Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2019-0130
Keywords
commercialization; cost taxonomy; cost-effectiveness analysis; nanotherapeutics; reimbursement